Clinical Trials
24
Active:18
Completed:4
Trial Phases
3 Phases
Phase 1:17
Phase 2:2
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials
Phase 1
17 (81.0%)Phase 2
2 (9.5%)Phase 3
2 (9.5%)Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4)
Phase 3
Completed
- Conditions
- Non Cystic Fibrosis Bronchiectasis
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-04-04
- Last Posted Date
- 2021-03-26
- Lead Sponsor
- Aradigm Corporation
- Target Recruit Count
- 304
- Registration Number
- NCT02104245
Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)
Phase 3
Completed
- Conditions
- Non Cystic Fibrosis Bronchiectasis
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-01-23
- Last Posted Date
- 2021-03-26
- Lead Sponsor
- Aradigm Corporation
- Target Recruit Count
- 278
- Registration Number
- NCT01515007
Evaluation of Ciprofloxacin for Inhalation to Cystic Fibrosis Patients With P. Aeruginosa
- First Posted Date
- 2010-03-23
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Aradigm Corporation
- Registration Number
- NCT01090908
Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1"
Phase 2
Completed
- Conditions
- Non-Cystic Fibrosis Bronchiectasis
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2017-01-25
- Lead Sponsor
- Aradigm Corporation
- Target Recruit Count
- 95
- Registration Number
- NCT00889967
- Locations
- 🇬🇧
"Ground Floor, Tower Block, Lisburn Road, Belfast, Britain, United Kingdom
🇬🇧"1st Floor, Nuffield House, B15 2TH, Birmingham, Britain, United Kingdom
🇬🇧"Duckworth Lane,, Bradford, Britain, United Kingdom
News
No news found